about
Astrocyte-mediated control of cerebral microcirculation.Zinc inhibits astrocyte glutamate uptake by activation of poly(ADP-ribose) polymerase-1.NF-κB transcriptional activation by TNFα requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons.Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitisAbility of nitrobenzylthioinosine to cross the blood-brain barrier in rats.Physiological Roles of Non-Neuronal NMDA Receptors.Astrocyte dysfunction in Alzheimer disease.Multifunctional role of astrocytes as gatekeepers of neuronal energy supplyProtection of cortical neurons from excitotoxicity by conjugated linoleic acid.Astrocytic poly(ADP-ribose) polymerase-1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity.Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal.Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide).Functional and immunocytochemical characterization of D-serine transporters in cortical neuron and astrocyte cultures.Cellular distribution of the neutral amino acid transporter subtype ASCT2 in mouse brain.Astrocytes drive cortical vasodilatory signaling by activating endothelial NMDA receptors.Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/nucleoside cotransporters in rat brain.Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain.Distribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain.Poly(ADP-ribose) polymerase-1 causes mitochondrial damage and neuron death mediated by Bnip3.
P50
Q35172968-0B9218A9-611B-4523-A6C3-B58F038DFED5Q35951558-58DDFBE0-4F1C-40A9-9CC4-73C84888373EQ36348582-A0D97B6F-9811-44C4-A16A-D8747717AFB4Q36431731-A6F931C3-6A95-450B-B2BF-B04CEE5CEE0DQ36808573-F64714E3-7B87-4253-97F6-91564E0C7629Q38351250-84C16944-3568-4425-ACD8-5A9383641B10Q38875009-863C94BF-0935-43F9-B796-77C8C5444BA8Q39280590-A28E55E8-37F5-4FC0-900A-4E3318ECD9CCQ39734463-1C935E31-BD15-452E-A66F-F989352EC17EQ42969504-AD692F88-1283-4C75-ADEC-E906EABAE5B1Q43268756-D9CD2612-54AA-4698-8FCF-0B298AB9DDB4Q43830040-5BE96514-DBE3-4B9E-BC61-1D588578E908Q43987358-5FC35A09-2111-4655-9AA9-C2462B3177FFQ45812286-A9E8E6C7-28BB-415A-A9B2-3D841919D2CCQ46243657-D2D4BF9B-3FDE-402A-A262-B0E0BEB008D2Q48000051-542E20BF-6D1A-4A94-B133-BD8AAD4904EDQ48057028-AF1276C6-8155-491D-9538-2B81F1DC4234Q48148868-ACF141D0-6AF8-4864-A69E-D219B7190659Q48162008-BE10BD69-9CB7-454F-83AC-14F77325A39BQ48445649-21850E39-F439-411E-9CC2-37A6F266520C
P50
description
hulumtues
@sq
neuroscientist and medical researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher M. Anderson
@ast
Christopher M. Anderson
@en
Christopher M. Anderson
@es
Christopher M. Anderson
@nl
Christopher M. Anderson
@sl
type
label
Christopher M. Anderson
@ast
Christopher M. Anderson
@en
Christopher M. Anderson
@es
Christopher M. Anderson
@nl
Christopher M. Anderson
@sl
altLabel
C M Anderson
@en
Christopher Anderson
@en
prefLabel
Christopher M. Anderson
@ast
Christopher M. Anderson
@en
Christopher M. Anderson
@es
Christopher M. Anderson
@nl
Christopher M. Anderson
@sl
P106
P1153
55319580300
P21
P31
P4012
P496
0000-0003-0678-3002